MedTrace Logo

INFLAMmatory BiomarkErs in COVID-19 Participants and Severity of Disease

NCT05175846 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-06-01

No results posted yet for this study

Summary

Observational Study of the Association of Immunological and Inflammatory Biomarkers in COVID-19 Naïve and Infected Participants and Severity of Disease. Thirty naive and 30 COVID positive participants will have a blood sample taken after informed consent and be assessed for COVID symptoms according to WHO classification. Participants will be followed monthly for 6 months. At each contact, participants will be assessed for COVID symptoms and progress since the previous visit.

Conditions

Sponsors & Collaborators

  • AccessDx Laboratories, Houston, TX

    collaborator UNKNOWN

  • Trinitas Global, LLC

    lead INDUSTRY

Principal Investigators

  • Robert A Monteleone, MD · Saint Francis Family Medicine Residency Program, Wilmington, Delaware

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-01-30
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05175846 on ClinicalTrials.gov